medline.ch Respirationstrakt Neoplasie

	The Incidence, Severity and Risk Factors of Renal Injury in Lung Cancer Patients Receiving Osimertinib Therapy: A Real-World Study. Cancer Med Lin J, Dong X, Tang W, Liu S. PMID: 41271435 [PubMed - indexed for MEDLINE]
	Integrating photon with proton dose-response data alters a pulmonary complication model-based patient selection in esophageal cancer. Radiother Oncol Liu Y, Populaire P, Draguet C, Haustermans K, Defraene G. PMID: 41271175 [PubMed - as supplied by publisher]
	Impact of the Lung Immune Prognostic Index in non-small-cell lung cancer patients with PD-L1-low/negative tumors receiving chemoimmunotherapy: a real-world multicenter retrospective study. ESMO Open Yoshimura A, Takeda T, Tanimura K, Chihara Y, Kawachi H, Yamanaka Y, Tamiya N, Honda R, Yamada T, Uryu K, Shiotsu S, Yoshioka H, Yamada T, Kurata T, Takayama K. PMID: 41270701 [PubMed - as supplied by publisher]
	Bevacizumab plus chemotherapy versus chemotherapy in untreated advanced non-squamous non-small-cell lung cancer patients with brain metastases (BAP BRAIN): an open-label, randomized, multicenter, phase III study. ESMO Open Li M, Pan Y, Jiang G, Wang Q, Wu G, Feng W, Zhou C, Bu Q, Ma S, Jiang H, Chen J, Yu H, Yu M, Liu Q, Hou X, Chen L. PMID: 41270700 [PubMed - as supplied by publisher]
	First-line treatment in EGFR-mutated non-small cell lung cancer: brief report of an individual patient data comparison of phase 3 clinical trials. Lung Cancer Torchia A, Sabatini A, Bengala E, Di Civita MA, Ciurluini F, Marinelli D, Giammaruco M, Laudisi A, Gelibter A, Minuti G, Landi L, Santini D, Cappuzzo F. PMID: 41270639 [PubMed - as supplied by publisher]
	Germline Variants in Indian Non-Small Cell Lung Cancer Patients With Familial Aggregation: A Prospective Cohort Study. Clin Lung Cancer Agrawal A, Chitikela SD, Rastogi A, Khurana S, Pushpam D, Pramanik R, Kumar A, Sharma A, Chettri M, Gupta I, Rathore A, Jain D, Kumar S, Malik PS. PMID: 41270309 [PubMed - as supplied by publisher]
	Impact of Histology and PD-L1 Status on Immune Checkpoint Inhibitors in the Treatment of Non-Small Cell Lung Cancer a Systemic Review and Meta-analysis. Clin Lung Cancer Choucair K, Jang H, Jalal SI, Hadid T, Uprety D, Kim S, Mamdani H. PMID: 41270307 [PubMed - as supplied by publisher]
	Meta-Analysis of Bias in Non-Small Cell Lung Cancer External Control Arms That Use Real-World Progression-Free Survival as the End Point. JCO Clin Cancer Inform Bahmane S, Harbron C, Incerti D, Ton TGN, Bretscher MT. PMID: 41270248 [PubMed - indexed for MEDLINE]
	Pulmonary Interventions for Bronchial Tumors: Case Studies. Clin J Oncol Nurs Mathew S. PMID: 41269735 [PubMed - indexed for MEDLINE]
	Association of Spirometric Lung Age with Survival Outcomes in Elderly Patients Undergoing Radical Surgery for Gastric Cancer. J Gastrointest Cancer Urabe M, Suzuki M, Fukai T, Hasegawa Y, Terai E, Kiya Y, Morizono G, Hiyoshi M, Watanabe T, Hashiguchi Y. PMID: 41269479 [PubMed - indexed for MEDLINE]
	Effectiveness of Shuanghuang Yangxue Decoction for Treating Cancer-Related Anemia With Serum Iron Deficiency in Lung Cancer Patients: A Randomized Clinical Trial. Integr Cancer Ther Li QY, Yang WX, Lu Y, Lin D, Mu H, Wang Q, Yao JL, Liu H, Yao LQ, Li X, Qiu WC, Xue PP, Qian C, Xu L, Shi J. PMID: 41268973 [PubMed - indexed for MEDLINE]
	Datopotamab deruxtecan versus docetaxel for non-small cell lung cancer: a plain language summary of the TROPION-Lung01 study. Future Oncol Sands J, Ahn MJ. PMID: 41268710 [PubMed - as supplied by publisher]
	Relationship between long-term outcomes and optimal time interval in patients with bilateral synchronous multiple primary lung cancers: a multi-institutional cohort study. Ann Med Guo W, Zhou B, Huai Q, Ji Y, Chen Y, He H, Han L, Li B, Zhou J, Tan F, Xue Q, Gao S, He J. PMID: 41268684 [PubMed - indexed for MEDLINE]
	Treatment-Related Adverse Events of Antibody-Drug Conjugate Monotherapy in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. Thorac Cancer Li Y, Zhou L, Li S, Zhou S, Chen Y, Tong Y, Sun J, Wang L, Fan Y. PMID: 41268683 [PubMed - indexed for MEDLINE]
	Study design and rationale for the NeoTRACE trial: a multicenter phase II study of neoadjuvant sacituzumab govitecan plus zimberelimab followed by adjuvant zimberelimab with or without sacituzumab govitecan in patients with resectable non-small cell lung cancer. Future Oncol Althoff FC, Acker F, Koschade S, Heinzen S, Aguinarte L, Rost M, Schulte H, Rohde G, Winter M, Schreiner W, Krause K, Grünwald V, Serve H, Oellerich T, Sebastian M. PMID: 41268635 [PubMed - as supplied by publisher]
	Identifying risk factors for refractory tyrosine kinase inhibitor-induced interstitial lung disease in patients with non-small cell lung cancer. Chin Clin Oncol Huang W, Ye H, Zhu Y, Huang M, Du S, Tan P. PMID: 41268624 [PubMed - as supplied by publisher]
	Role of the SOX family in nonâ€‘small cell lung cancer: Molecular mechanisms and therapeutic implications (Review). Oncol Rep Wang K, Li Y, Guo Z, Song L, Ding X, Liu L, Hu T, Bian Y, Huang C, Miao L. PMID: 41268614 [PubMed - indexed for MEDLINE]
	Overcoming resistance to immune checkpoint inhibitor in non-small cell lung cancer: the promise of combination therapy. Front Immunol Shi X, Deng W, Pan Y, Chen Y, Wang Y, Wu J. PMID: 41268560 [PubMed - indexed for MEDLINE]
	Advancements in extensive-stage small cell lung cancer therapy: from molecular profiling to the advent of precision oncology. Front Immunol Yang C, Shao Y, Zhang Y, Zhang H, Zhao Y. PMID: 41268540 [PubMed - indexed for MEDLINE]
	Gut microbiota and metabolites: emerging prospects in the treatment of non-small cell lung cancer. Front Immunol Jiao JM, Liu CG, Zang D, Chen J. PMID: 41268538 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 154257

Seite 1 von 7713



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung